Phimedix PLC Result of AGM (1032B)

TIDMPHM

RNS Number : 1032B

Phimedix PLC

05 October 2020

5 October 2020

Phimedix Plc

("Phimedix" or "the Company")

Result of Annual General Meeting

The Board of Phimedix is pleased to announce the results of the voting on the resolutions at its Annual General Meeting, held earlier today. A poll was held on each of the resolutions and all resolutions were passed by the requisite majority. Resolutions 1-4 (inclusive) were passed as ordinary resolutions and resolution 5 was passed as a special resolution.

The Poll results are set out below:

 
 Resolution                   Votes for      % of          Votes     % of   Votes total   % of total   Abstained 
                                 (incl.     votes        against    votes                     voting 
                             Chairman's                                                       rights 
                            discretion) 
 1. The approval 
  of the accounts 
  of the Company for 
  the year ended 31 
  March 2020                  9,685,176   100.00%            Nil    0.00%     9,685,176       28.15%       2,500 
                          -------------  --------  -------------  -------  ------------  -----------  ---------- 
 2. The re-election 
  of Nicholas Nelson 
  as a Director of 
  the Company                 9,006,811   100.00%            Nil    0.00%     9,006,811       26.18%     680,865 
                          -------------  --------  -------------  -------  ------------  -----------  ---------- 
 3. The re-appointment 
  of Jeffreys Henry 
  LLP as auditors 
  and to authorise 
  the Directors to 
  fix the auditors' 
  remuneration                9,685,176   100.00%            Nil    0.00%     9,685,176       28.15%       2,500 
                          -------------  --------  -------------  -------  ------------  -----------  ---------- 
 4. To authorise 
  the Directors to 
  allot shares in 
  the Company pursuant 
  to Section 551 of 
  the Act                     9,685,176   100.00%            Nil    0.00%     9,685,176       28.15%       2,500 
                          -------------  --------  -------------  -------  ------------  -----------  ---------- 
 5. To disapply the 
  statutory pre-emption 
  rights under Section 
  561 of the Act              9,685,176   100.00%            Nil    0.00%     9,685,176       28.15%       2,500 
                          -------------  --------  -------------  -------  ------------  -----------  ----------

End

For further information please contact:

 
 Phimedix Plc                                    Please email any enquiries 
  Nicholas Nelson, Director                         to nelson@nexfin.org.uk 
  Ajay Rajpal, Director 
 
   SPARK Advisory Partners Limited (Nominated 
   Adviser) 
   Mark Brady or Neil Baldwin 
   www.sparkadvisorypartners.com                       +44 (0) 203 368 3550 
 
   SI Capital Ltd (Broker) 
   Nick Emerson 
   www.sicapital.co.uk                                   +44 (0)1483 413500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGKELBBBBLXFBK

(END) Dow Jones Newswires

October 05, 2020 05:45 ET (09:45 GMT)

Phimedix (LSE:PHM)
Historical Stock Chart
From Nov 2024 to Dec 2024